Sidney Taurel
Sidney Taurel
Sidney Taurelis a Moroccan-born American businessman. He is the former Chairman and Chief Executive Officer of Eli Lilly and Company. He became chief executive officer in July 1998 and chairman of the board of directors on January 1, 1999. He was succeeded as chief executive officer by John C. Lechleiter on April 1, 2008. He now serves as an advisor at Moelis & Company...
appeals asking case decision fails option supreme
We are asking for a rehearing on the decision by the appeals court, and if that fails we have the option of going to the Supreme Court, so the case is not over,
building importance launching pipeline quarter strong
While the first quarter was a challenging quarter, it underscores the importance of building a strong pipeline and effectively launching new products,
address bring closely committing company continue deliver fda innovative medicines necessary order patients promise quickly resources work
I am committing all the necessary resources of the company to address these issues, ... We will continue to work closely with the FDA in order to deliver on our promise to bring these innovative new medicines to patients as quickly as possible.
destiny execute help structure
Now that we've done all this, our destiny is in our hands. It's up to us to perform. This new structure will help us better execute our strategy.
abide actions activities although assure business charged committed continue deeply designed ensuring ethical federal fully governing government highest laws legal practices reflect regret remain resulted seriously standards steps
We deeply regret the 1998 conduct, which has resulted in a federal misdemeanor charge. We take seriously our responsibilities to abide by all the laws governing our business practices and are committed to ensuring our employees' actions reflect the highest legal and ethical standards of conduct. Although the government has not charged Lilly with any unlawful intent, we will continue to take steps designed to assure that Lilly's promotional activities remain fully compliant.
existing extensions growth less line next overall product products prozac quarters recent rely sales several
Our overall growth for the next several quarters will be generated from newer product sales, line extensions of existing products and recent product launches, ... As a result, we will rely less on Prozac sales growth.
expectation overall
I think there is an overall unreasonable expectation right now that there is such a thing as a risk-free drug.
earnings forward grow growth looking percent products share
Looking forward to 2006, our newer products should grow to about 24 percent of revenues and earnings per share should grow 8 to 11 percent, representing top-tier growth for large-cap pharmaceutical companies.
commitment execution faster grow quarter rate reflect results sales strong
Our strong bottom-line results in the first quarter reflect the execution on our commitment to grow sales at a faster rate than our expenses.
adjusted anticipate average compared consensus deliver double earnings expect expected fact forecast given growth major nearly patent per rate represents rest share street sustained uniquely wall
Given our products, pipeline, and the fact that we expect no major patent expirations for the rest of this decade, Lilly is uniquely positioned to deliver sustained earnings growth. For 2006, we anticipate earnings per share of $3.10 to $3.20, which represents 8% to 12% growth compared with expected 2005 adjusted earnings. This growth rate is nearly double the average Wall Street consensus forecast for large-cap pharmaceutical companies.
forward join leadership role senior vital
He is very well-prepared for the vital role he will play, and I look forward to having him join our senior leadership team.
access affordable best care disaster ensure founders health nearly needing patients people survivors values whether
Whether they are patients needing access to affordable health care or survivors of a disaster, we do our best to ensure that people in need are not forgotten. Our founders established these values nearly 130 years ago, and we live by them today.
built class financial reputation sound
Through Charlie's leadership, we have built a world-class financial organization and strengthened Lilly's reputation for sound financial operations.
economy growing region resilient seeing seems
We are seeing a very resilient economy and one that seems to be growing in every part of the world. Just about every region is growing and it's very encouraging.